MyFinsight
Home
Blog
About
Contact
alzn: the income statement
Download
Download image
Net loss available
to common shares
-$1,000,758
Net loss
-$1,000,758
Total other expense,
net
-$2,649
Loss from operations
-$998,109
Interest expense
$2,649
Total operating
expenses
$998,109
General and
administrative
$821,826
Research and development
$176,283
Back
Back
Income Statement
source: myfinsight.com
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)